zSpace (NASDAQ:ZSPC) Stock Rating Upgraded by Roth Capital
zSpace (NASDAQ:ZSPC – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a report issued on Monday,Zacks.com reports....
zSpace (NASDAQ:ZSPC) Stock Rating Upgraded by Roth Capital
zSpace (NASDAQ:ZSPC – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a report issued on Monday,Zacks.com reports....
zSpace (NASDAQ:ZSPC) Stock Rating Upgraded by Roth Capital
zSpace (NASDAQ:ZSPC – Get Free Report) was upgraded by stock analysts at Roth Capital to a “strong-buy” rating in a report issued on Monday,Zacks.com reports....
Christopher Peetz Sells 9,102 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 9,102 shares of the stock in a transaction on Monday, February 3rd. The...
Christopher Peetz Sells 9,102 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 9,102 shares of the stock in a transaction on Monday, February 3rd. The...
Christopher Peetz Sells 9,102 Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Stock
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) CEO Christopher Peetz sold 9,102 shares of the stock in a transaction on Monday, February 3rd. The...